Article ID: 622670
A Vaccine for Ebola?University of Vermont
To learn more about this outbreak and the creation of new human vaccines, Vermont Medicine, a publication of the University of Vermont College of Medicine, talked to infectious disease experts Beth Kirkpatrick, M.D., UVM Vaccine Testing Center director, and Kristen Pierce, M.D., who have led vaccine studies for such global pathogens as cholera, West Nile virus, dengue, typhoid fever and anthrax.
Released:29-Aug-2014 3:00 PM EDT
Article ID: 622643
AJRCCM Releases ‘Caring for Critically Ill Patients with Ebola Virus Disease: Perspectives from West Africa’American Thoracic Society (ATS)
The largest-ever Ebola virus disease outbreak is ravaging West Africa, but with more personnel, basic monitoring, and supportive treatment, many of the sickest patients with Ebola virus disease do not need to die, note the authors of a new paper published ahead of print publication in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Released:29-Aug-2014 8:50 AM EDT
Article ID: 622441
As Ebola Rages, Controlling the Deadly SpreadRutgers University
As the out-of-control Ebola epidemic continues, an infectious disease physician and a medical historian -- both at Rutgers University -- discuss the risk for Americans, lessons from medical history, and treating people already at risk.
Released:25-Aug-2014 10:00 AM EDT
Article ID: 622355
Op-Ed: Nurses Know Danger, Forge Ahead on Ebola CareJohns Hopkins School of Nursing
Ever since Florence Nightingale, “The Lady With the Lamp,” took it upon herself to care for the sick and the wounded in the Crimean War in the 1850s, nurses have proven their value and their valor where care is most daunting and risky.
Released:21-Aug-2014 3:30 PM EDT
Article ID: 622199
Media Advisory: Hopkins Bioethicist Defends Treatment of American Ebola PatientsJohns Hopkins Medicine
Public health ethics expert Nancy Kass defends the unique treatment given to the two Americans who contracted the Ebola virus and cautions against rapid, widespread dissemination of experimental treatments.
Released:18-Aug-2014 4:00 PM EDT
Article ID: 622074
Wolters Kluwer Health Supports Relief Efforts with Ebola Outbreak in AfricaWolters Kluwer Health: Lippincott Williams and Wilkins
The Ebola virus disease (EVD) outbreak in West Africa has been called an international public health emergency by the World Health Organization. In response to this health crisis, Wolters Kluwer Health announced today its participation in the U.S. National Library of Medicine’s (NLM) Emergency Access Initiative (EAI) by providing 55 Lippincott Williams & Wilkins (LWW) medical, nursing and allied health specialty journals during a four week free access period from August 14 – September 11, 2014. Healthcare providers will have access to major biomedicine titles to support emergency treatment and patient care of this infectious disease.
Released:18-Aug-2014 9:15 AM EDT